Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
Journal
Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
aheadofprint:
13
02
2020
received:
06
09
2019
accepted:
07
02
2020
pubmed:
15
2
2020
medline:
22
5
2021
entrez:
15
2
2020
Statut:
epublish
Résumé
Bone marrow failure (BMF) related to hypoplasia of hematopoietic elements in the bone marrow is a heterogeneous clinical entity with a broad differential diagnosis including both inherited and acquired causes. Accurate diagnostic categorization is critical to optimal patient care and detection of genomic variants in these patients may provide this important diagnostic and prognostic information. We performed real-time, accredited (ISO15189) comprehensive genomic characterization including targeted sequencing and whole exome sequencing in 115 patients with BMF syndrome (median age 24 years, range 3 months - 81 years). In patients with clinical diagnoses of inherited BMF syndromes, acquired BMF syndromes or clinically unclassifiable BMF we detected variants in 52% (12/23), 53% (25/47) and 56% (25/45) respectively. Genomic characterization resulted in a change of diagnosis in 30/115 (26%) including the identification of germline causes for 3/47 and 16/45 cases with pre-test diagnoses of acquired and clinically unclassifiable BMF respectively. The observed clinical impact of accurate diagnostic categorization included choice to perform allogeneic stem cell transplantation, disease-specific targeted treatments, identification of at-risk family members and influence of sibling allogeneic stem cell donor choice. Multiple novel pathogenic variants and copy number changes were identified in our cohort including in TERT, FANCA, RPS7 and SAMD9. Whole exome sequence analysis facilitated the identification of variants in two genes not typically associated with a primary clinical manifestation of BMF but also demonstrated reduced sensitivity for detecting low level acquired variants. In conclusion, genomic characterization can improve diagnostic categorization of patients presenting with hypoplastic BMF syndromes and should be routinely performed in this group of patients.
Identifiants
pubmed: 32054657
doi: 10.3324/haematol.2019.237693
pmc: PMC7776333
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
64-73Commentaires et corrections
Type : CommentIn
Références
J Allergy Clin Immunol. 2015 Nov;136(5):1337-45
pubmed: 26025129
Am J Med Genet A. 2016 Feb;170A(2):386-391
pubmed: 26590883
Blood. 2011 Dec 22;118(26):6943-51
pubmed: 22045982
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
J Clin Invest. 2014 Oct;124(10):4529-38
pubmed: 25244093
Am J Hum Genet. 1999 Nov;65(5):1330-41
pubmed: 10521298
Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37
pubmed: 18635888
Leukemia. 2019 Oct;33(10):2495-2505
pubmed: 30940907
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Am J Hum Genet. 2018 Dec 6;103(6):930-947
pubmed: 30503522
Nat Genet. 1999 Feb;21(2):169-75
pubmed: 9988267
Anemia. 2012;2012:238731
pubmed: 22693659
Clin Genet. 2012 Jan;81(1):76-81
pubmed: 21199492
Blood. 2018 Sep 20;132(12):1318-1331
pubmed: 29914977
Nat Genet. 2010 May;42(5):406-9
pubmed: 20400963
J Clin Pathol. 2018 Oct;71(10):895-899
pubmed: 29760015
Blood. 2014 Oct 23;124(17):2698-704
pubmed: 25139356
Blood. 2008 Nov 1;112(9):3594-600
pubmed: 18669893
Leuk Res. 2018 Jun;69:54-59
pubmed: 29656215
Hum Mutat. 2008 Jan;29(1):159-66
pubmed: 17924555
Curr Opin Hematol. 2015 Jan;22(1):3-11
pubmed: 25427142
Blood. 2016 Feb 25;127(8):1017-23
pubmed: 26712909
Haematologica. 2018 Mar;103(3):417-426
pubmed: 29269525
Clin Genet. 2015 Jul;88(1):68-73
pubmed: 24989076
Br J Haematol. 2009 Mar;144(5):762-70
pubmed: 19036076
Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741):
pubmed: 29335378
Curr Opin Pediatr. 2011 Feb;23(1):21-6
pubmed: 21206270
Sci Rep. 2019 Apr 23;9(1):6426
pubmed: 31015508
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Med Genet. 2015 Sep;52(9):575-84
pubmed: 26136524
Genet Med. 2018 Apr;20(4):452-457
pubmed: 28837162
Gene. 2013 Nov 10;530(2):295-300
pubmed: 23973728
J Clin Invest. 2017 Nov 1;127(11):4090-4103
pubmed: 28972538
Blood. 1999 Dec 15;94(12):4294-306
pubmed: 10590074
Nucleic Acids Res. 2015 Nov 16;43(20):9835-55
pubmed: 26354865
Blood. 2017 Apr 20;129(16):2266-2279
pubmed: 28202457
Br J Haematol. 2016 Jan;172(2):187-207
pubmed: 26568159
Pediatr Blood Cancer. 2009 Dec;53(6):1143-6
pubmed: 19499579
Anemia. 2012;2012:603253
pubmed: 22778927
Haematologica. 2012 May;97(5):723-30
pubmed: 22180437
Blood. 2000 Oct 1;96(7):2317-22
pubmed: 11001877
J Biol Chem. 2012 Jan 27;287(5):3366-80
pubmed: 22167183
Am J Hum Genet. 2016 Jun 2;98(6):1146-1158
pubmed: 27259050
Blood. 2018 Sep 13;132(11):1211-1215
pubmed: 30030275
N Engl J Med. 2015 Jul 2;373(1):35-47
pubmed: 26132940